Drugs Information: Atezolizumab
Basic Information
|
||
| ID | DDInter131 | |
| Drug Type | biotech | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| Description | Atezolizumab is a monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. | |
| ATC Classification | L01XC32 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Atezolizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|